Literature DB >> 17940942

Assessment of the risk of Ebola virus transmission from bodily fluids and fomites.

Daniel G Bausch1, Jonathan S Towner, Scott F Dowell, Felix Kaducu, Matthew Lukwiya, Anthony Sanchez, Stuart T Nichol, Thomas G Ksiazek, Pierre E Rollin.   

Abstract

Although Ebola virus (EBOV) is transmitted by unprotected physical contact with infected persons, few data exist on which specific bodily fluids are infected or on the risk of fomite transmission. Therefore, we tested various clinical specimens from 26 laboratory-confirmed cases of Ebola hemorrhagic fever, as well as environmental specimens collected from an isolation ward, for the presence of EBOV. Virus was detected by culture and/or reverse-transcription polymerase chain reaction in 16 of 54 clinical specimens (including saliva, stool, semen, breast milk, tears, nasal blood, and a skin swab) and in 2 of 33 environmental specimens. We conclude that EBOV is shed in a wide variety of bodily fluids during the acute period of illness but that the risk of transmission from fomites in an isolation ward and from convalescent patients is low when currently recommended infection control guidelines for the viral hemorrhagic fevers are followed.

Entities:  

Mesh:

Year:  2007        PMID: 17940942     DOI: 10.1086/520545

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  185 in total

1.  Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method.

Authors:  Yohei Kurosaki; Allen Grolla; Aiko Fukuma; Heinz Feldmann; Jiro Yasuda
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

2.  Ebola: Hidden reservoirs.

Authors:  Jonathan L Heeney
Journal:  Nature       Date:  2015-11-26       Impact factor: 49.962

Review 3.  Clinical development of Ebola vaccines.

Authors:  Saranya Sridhar
Journal:  Ther Adv Vaccines       Date:  2015-09

Review 4.  Ebola Virus Disease: Focus on Children.

Authors:  Athena P Kourtis; Kristie Appelgren; Michelle S Chevalier; Anita McElroy
Journal:  Pediatr Infect Dis J       Date:  2015-08       Impact factor: 2.129

Review 5.  Live neonates born to mothers with Ebola virus disease: a review of the literature.

Authors:  J M Nelson; S E Griese; A B Goodman; G Peacock
Journal:  J Perinatol       Date:  2015-12-10       Impact factor: 2.521

6.  Comparison of surface sampling methods for virus recovery from fomites.

Authors:  Timothy R Julian; Francisco J Tamayo; James O Leckie; Alexandria B Boehm
Journal:  Appl Environ Microbiol       Date:  2011-08-05       Impact factor: 4.792

7.  A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.

Authors:  Igor Opsenica; James C Burnett; Rick Gussio; Dejan Opsenica; Nina Todorović; Charlotte A Lanteri; Richard J Sciotti; Montip Gettayacamin; Nicoletta Basilico; Donatella Taramelli; Jonathan E Nuss; Laura Wanner; Rekha G Panchal; Bogdan A Solaja; Sina Bavari
Journal:  J Med Chem       Date:  2011-01-25       Impact factor: 7.446

8.  Use of the FilmArray System for Detection of Zaire ebolavirus in a Small Hospital in Bo, Sierra Leone.

Authors:  Tomasz A Leski; Rashid Ansumana; Chris R Taitt; Joseph M Lamin; Umaru Bangura; Joseph Lahai; George Mbayo; Mohamed B Kanneh; Ben Bawo; Alfred S Bockarie; Matt Scullion; Cynthia L Phillips; Cynthia P Horner; Kathryn H Jacobsen; David A Stenger
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

Review 9.  Ebola virus disease.

Authors:  Nicholas J Beeching; Manuel Fenech; Catherine F Houlihan
Journal:  BMJ       Date:  2014-12-10

10.  Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.

Authors:  James E Strong; Gary Wong; Shane E Jones; Allen Grolla; Steven Theriault; Gary P Kobinger; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.